SIRT1 and in situ carcinoma: SIRT1 protected the kidney against CIS-induced injury by deacetylating NF-κB and p53 and inhibiting inflammation [27] and ameliorated ALI in lipopolysaccharide (LPS)-challenged mice by decreasing endothelial tight junction permeability and suppressing inflammation [28].